Peter Guenter
Director/Board Member presso GALAPAGOS NV
Patrimonio netto: 63 637 $ in data 31/03/2024
Profilo
Mr. Peter Guenter is a Member-Management Board & CEO-Healthcare at Merck KGaA and an Independent Non-Executive Director at Galapagos NV.
He is on the Board of Directors at Galapagos NV and European Federation of Pharmaceutical Industries & Assns.
Mr. Guenter was previously employed as a Chief Executive Officer & Director by Almirall SA, an Executive Vice President by Smithkline Beecham, an EVP, General Manager-Diabetes & Cardiovascular by Sanofi, and a Chairman-Supervisory Board by Sanofi-Aventis Deutschland GmbH.
He received his graduate degree from Ghent University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
GALAPAGOS NV
0.00% | 15/03/2024 | 1 992 ( 0.00% ) | 63 637 $ | 31/03/2024 |
Posizioni attive di Peter Guenter
Società | Posizione | Inizio |
---|---|---|
GALAPAGOS NV | Director/Board Member | 30/04/2019 |
MERCK KGAA | Corporate Officer/Principal | 01/01/2021 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Director/Board Member | - |
Precedenti posizioni note di Peter Guenter
Società | Posizione | Fine |
---|---|---|
ALMIRALL, S.A. | Chief Executive Officer | 31/12/2020 |
SANOFI | Corporate Officer/Principal | 01/08/2017 |
Smithkline Beecham | Corporate Officer/Principal | - |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Chairman | - |
Formazione di Peter Guenter
Ghent University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
MERCK KGAA | Health Technology |
SANOFI | Health Technology |
GALAPAGOS NV | Health Technology |
ALMIRALL, S.A. | Health Technology |
Aziende private | 3 |
---|---|
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Health Technology |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
Smithkline Beecham |
- Borsa valori
- Insiders
- Peter Guenter